INNOVATE (VATE)
Operating a diversified portfolio of construction, life-sciences and broadcasting platforms.
$8.04
vs last close−0.14 (−1.71%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 375 | 361 | 315 | 313 | 242 | 237 | 274 | 242 | 347 | 383 | 365 | 422 |
| Cost of revenue | 317 | 300 | 267 | 248 | 194 | 190 | 233 | 196 | 302 | 328 | 316 | 342 |
| Gross profit | 59 | 61 | 49 | 66 | 48 | 46 | 41 | 46 | 45 | 55 | 49 | 80 |
| 48 | 47 | 46 | 37 | 42 | 44 | 37 | 41 | 38 | 39 | 38 | 45 | |
| Selling, general & administrative | 0 | 0 | 0 | 43 | 0 | 40 | 37 | 0 | 38 | 39 | 38 | 42 |
| Other expenses | 48 | 47 | 46 | −6 | 42 | 4 | 0 | 41 | 0 | 0 | 0 | 4 |
| Operating income | 11 | 14 | 3 | 29 | 6 | 3 | 4 | 5 | 7 | 15 | 11 | 35 |
| −18 | −23 | −20 | −17 | −19 | −17 | −23 | −22 | −24 | −25 | −25 | −9 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest expense | 17 | 19 | 17 | 17 | 21 | 20 | 20 | 21 | 23 | 24 | 25 | 28 |
| Other non-operating income | 0 | −1 | 2 | 1 | −2 | −2 | 3 | 0 | 0 | 1 | 1 | −19 |
| Income before tax | −8 | −9 | −17 | 11 | −13 | −15 | −19 | −17 | −17 | −9 | −14 | 26 |
| Income tax expense | 1 | 1 | 3 | −3 | 3 | 2 | 7 | 4 | −7 | −2 | 3 | 13 |
| Net income from continuing operations | −9 | −11 | −20 | 14 | −16 | −17 | −26 | −21 | −10 | −8 | −17 | 12 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −3 |
| Net income | −7 | −9 | −17 | 14 | −15 | −17 | −25 | −20 | −9 | −7 | −17 | 11 |
| EPS, basic | −$0.93 | −$1.22 | −$2.25 | $1.58 | −$1.16 | −$1.29 | −$1.89 | −$1.67 | −$0.71 | −$0.58 | −$1.29 | $0.74 |
| EPS, diluted | −$0.93 | −$1.22 | −$2.25 | $0.98 | −$1.16 | −$1.29 | −$1.89 | −$1.67 | −$0.71 | −$0.58 | −$1.29 | $0.71 |
| Weighted average shares, basic | 8 | 8 | 8 | 9 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Weighted average shares, diluted | 8 | 8 | 8 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 |
| EBITDA | 19 | 23 | 9 | 36 | 16 | 13 | 9 | 12 | 14 | 22 | 18 | 57 |
| Depreciation & amortization | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 8 | 7 | 4 |
| EBIT | 11 | 15 | 0 | 28 | 8 | 5 | 2 | 5 | 7 | 15 | 10 | 53 |
